Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Continuous Glucose Monitoring in Peri-operative Period in Kidney Transplant Recipients
Condition: New Onset Diabetes After Transplantation Intervention: Diagnostic Test: continuous glucose monitoring Sponsor: Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Investigation of the Effects of Quadratus Lumborum Block Applied to Patients in Kidney Transplant Surgery
Conditions: Kidney Transplant Recipient; Kidney Transplant Donor Intervention: Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Continuous Glucose Monitoring in Peri-operative Period in Kidney Transplant Recipients
Condition: New Onset Diabetes After Transplantation Intervention: Diagnostic Test: continuous glucose monitoring Sponsor: Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
